Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

MedShift Accelerates Tech in 2022 Key Figures and 2022 Results


MedShift has seen 40% overall revenue growth year over year, and that is especially highlighted by significant demand in our Technology division, which witnessed year-over-year growth of more than 88%

In its seventh year of business, Charlotte-based medical-technology company, MedShift, continued to lead in the aesthetic industry, with recognition by Inc 5000, Titan Business Awards, and Charlotte Business Journal. MedShift is delivering on its commitment to innovation through tech enabled solutions that solve key challenges for the most reputable OEM’s in aesthetics. Under the leadership of CEO Joe Gasque, MedShift continued its steady profitable delivery. “This year we have exceeded our goals through great partnerships with our OEM’s and clinician practices. I am very proud that we have continued to attract, retain and grow a high performing MedShift Team that grew to 30 teammates in 2022. MedShift has seen 40% overall revenue growth year over year, and that is especially highlighted by significant demand in our Technology division, which witnessed year-over-year growth of more than 88%. I could not be more proud of the team and the dedication and execution achieved throughout this year,” says Gasque.

The Technology team, led by VP of Engineering Adam Walsh, continues its path of innovation and feature rich product launches. The Software team has implemented SaaS Fintech, Sales Enablement, and eCommerce solutions for multiple aesthetic manufacturers while reducing costs and improving customer satisfaction. Adam Walsh, VP of Engineering, says, “Our team achieved significant milestones enabling scale and efficiency across the prior twelve months. Now shipping our embedded IoT modules for real time device reporting globally as well as creating a turn key platform for Ideal Curves, a pay-per-use medical device. It’s fulfilling to see MedShift deliver enterprise software solutions across the spectrum of medical device, injectable, and implant manufacturers in the aesthetic space and I am looking forward to a breakthrough announcement in Q1 of 2023.”

One of the newest hires early in 2022 was Sean Shapiro as Chief Commercial Officer. Shapiro has successfully navigated multiple commercial product launches, led sales teams, and built infrastructure that helped lead combined acquisition value north of a billion dollars for companies including Soliton, Ulthera, and CoolSculpting. Shapiro shares, “MedShift’s commercial business has grown significantly in 2022 due to the strong partnership we have with our OEM partners. Our OEM partnerships are set in our core beliefs focused on being Humble, Hungry and Customer Focused.” MedShift’s device business continues to thrive as we expand our portfolio with the latest technology available. CEO Gasque has this to say about MedShift’s device growth, “I am very excited for the demand MedShift has seen this year. As a company that centers around our people and partners, I am very happy to be expanding deep and broad relationships with our Manufacturer partners and with our 1800 clinical practices.”

MedShift’s marketing arm launched an overhaul of the Company’s store which supports the direct to clinician sale of the company’s consumable and injectable portfolio. Chief Commercial Officer, Sean Shapiro, says, “We have seen some amazing and truly unprecedented market demand for our device, technology, and injectable/consumable portfolio. As a technology and aesthetic company, it is important that we are building innovative, beautiful platforms to best serve our customers. I think this new iteration of the store reflects this well.” The store continues to expand its offerings, adding in exosome systems from EXO|E and Aesthetic Management Partners, GE Healthcare’s handheld ultrasound VScan Air and multiple skincare products from AMP skin care.”

2022 did not see MedShift slow down, and 2023 is expected to be another exciting year with innovative technology releases, additional products integrated to the broad portfolio, as well as the continued expansion of the talented team. In the new year, the company has high expectations for revenue growth, client expansion, and overall product development, with a special highlight in SaaS and IoT technology.

About MedShift

MedShift, founded in 2015 in Charlotte, NC, is a uniquely positioned medical technology company, serving as a valuable supply chain solution linking providers and suppliers in the fragmented, rapidly changing aesthetics industry. MedShift offers unparalleled value to aesthetic focused surgeons and practitioners by bundling leading medical devices with its proprietary technology, services, and access to discounted consumables. For suppliers, MedShift is a large device customer, serving as an access point to fragmented end markets while accelerating sales velocity, as well as a provider of proprietary enterprise software and technology solutions. Additionally, in its first year of eligibility, MedShift ranked 185 on the 2020 Inc. 5000 list, leading as the 15th fastest growing health company in the United States.

Share article on social media or email:

RevSpring and Azalea Health Partner to Integrate RevSpring’s PersonaPay™ and Azalea Portal Experiences to Increase Patient Convenience and Payments


“Thanks to this comprehensive collaboration with RevSpring, our growing network of providers and their patients gain access to the most sophisticated technology solutions available today,” said Azalea Health CEO Baha Zeidan.

RevSpring, the leading provider of healthcare engagement and payment solutions, today announced an extensive new partnership with Azalea Health, the leading provider of cloud-based healthcare IT solutions and services for community-based healthcare providers and patients, which fully integrates Azalea Health’s platform with RevSpring’s market leading PersonaPay™ patient payments portal, merchant services and billing engagement solutions. Azalea Health now offers its providers a full-service solution to drive increased patient satisfaction, reduced administrative work, and faster and more efficient patient payments and processing.

Azalea Health customers automatically benefit from RevSpring’s industry leading billing engagement services for patient statements as part of RevSpring’s new preferred vendor status with Azalea, as well as automated inbound payments using Interactive Voice Response (IVR) and Text-to-Pay, which allows patients to pay anywhere from their phone with just a few clicks.

“This new partnership provides an important expansion of RevSpring’s mission to deliver more value to providers and their patients,” said RevSpring CEO Scott MacKenzie. “We are delighted to collaborate with a company that shares our commitment to patient satisfaction, state-of-the-art technology and the reduction of administrative hassles.”

“Azalea’s provider-first platform will now further maximize positive outcomes for patients and providers,” said Azalea Health CEO Baha Zeidan. “Thanks to this comprehensive collaboration with RevSpring, our growing network of providers and their patients gain access to the most sophisticated technology solutions available today. Best of all, this streamlined and integrated solution is full-service and allows our customers and their patients to remain in the Azalea platform for ultimate convenience and a better overall experience.”

Other key features of PersonaPay and its Merchant Services include:

  • Automated settlement-based reconciliation that cuts manual reconciliation time in half
  • Simplified and streamlined underwriting, which eliminates the need for multiple vendors to process patient payments and related merchant services
  • Personalized payment plans to fit each patient’s needs
  • Deviceless Payments to allow customer service and front-line staff to securely take payments over the phone and in person without any access to private patient credit card or banking information
  • A wide array of payment methods, including Apple Pay® and Google Pay™

RevSpring and Azalea Health share a strong commitment to collaboration that provides a better, more robust and easier overall patient engagement experience.

About Azalea Health

Azalea Health is changing the way IT platforms connect community-based healthcare providers and patients across the lifecycle of care. Offering a 100% cloud-based integrated solution, Azalea delivers electronic health records and revenue cycle management designed for rural and community practices and hospitals. Quick to deploy and intuitive to use, Azalea solutions ensure better care coordination and communication—enabling better outcomes and a meaningful competitive advance. For more information, visit AzaleaHealth.com.

About RevSpring

RevSpring leads the market in healthcare engagement and payment solutions that inspire patients to participate in and pay for their healthcare. The company has built the industry’s most comprehensive and impactful patient engagement suite, spanning the clinical, operational and payment experience. RevSpring’s OmniChannel communications and payment solutions are backed by behavior analysis, propensity-to-pay scoring, contextual messaging, and user experience best practices. Using proprietary data analytics to tailor the engagement from preservice to post-service, RevSpring improves the patient experience and outcomes for providers, members and patients. To learn more, visit revspringinc.com/healthcare.

Share article on social media or email:

Validation Institute Recognizes Texas Medical Management for its Health Outcomes


Texas Medical Management (TMM) announced today that it has achieved validation for its health outcomes, producing significant improvements in outcome scores pre- and post-surgery measured at a fair and transparent price from Validation Institute.

Validation Institute is an independent organization that verifies the performance claims of healthcare solution providers. “Texas Medical Management does an exceptional job improving patient outcomes in surgical treatments, delivering a measurable, and positive impact on patients’ lives. Validation Institute is proud to validate TMM and recognize the profound impact on the healthcare ecosystem,” said Benny DiCecca, CEO of Validation Institute.

Texas Medical Management uses the value-based health care model to offer surgical services. TMM chooses surgeons and facilities for their quality outcomes and reputations and offers its patients better outcomes per total cost of a surgery bundle.

Founded in 2016, TMM has grown rapidly and began measuring patient outcomes in 2018. In 2020, TMM invested in the development of a team of data analysts who specialize in outcomes measurement. The Health Outcomes Team, which now operates independently as Integrity Insights, provides valuable insights that are shared with its surgeons. The TMM team prides itself in collecting patient outcomes that inform surgeons and patients with clear, actionable, and useful information.

“TMM is committed to partnering with good doctors and making it easy for them to care for their patients. We strive to constantly improve by helping doctors communicate and agree on the postoperative expectations for the procedure proposed preoperatively. The result is an unparalleled provider-patient relationship, steeped in streamlined communication so that patients get the care and conversation they need, and pay one bill for their surgical condition from beginning to end,” said Sean Kelley, Founder and Managing Partner of Texas Medical Management.

As part of its recognition, Validation Institute provides a $25,000 guarantee as part of its Credibility Guarantee Program for Texas Medical Management’s value-based healthcare model for outcomes. The validation report can be accessed here:

https://validationinstitute.com/validated-provider/texas-medical-management.

About Validation Institute

Validation Institute is a membership organization made up of a network of healthcare vendors, health benefits advisors, and purchaser benefit managers focused on delivering better health value and stronger outcomes than conventional healthcare. https://validationinstitute.com

About Texas Medical Management

Texas Medical Management is a Free Market Medicine solution in Texas for surgical procedures, which offers competitive, transparent prices on surgical procedures across a broad range of specialties, both outpatient and inpatient. Texas Medical Management’s mission is to deliver the highest quality care at transparent, competitive prices.

https://texasmedicalmanagement.com

Share article on social media or email:

AprilAire Gives Away Thousands of Free Radon Test Kits in January for National Radon Action Month


News Image

“We are on a mission to help people stay safe in their homes so, to help raise awareness about radon, we’re giving away thousands of tests,” said Jens Housley, AprilAire’s senior category manager for radon.

AprilAire, the nationwide leader in professional-grade Indoor Air Quality (IAQ) solutions for the home since 1954, is marking a year in the radon mitigation business by giving away thousands of radon tests in January to Wisconsin and Pennsylvania residents to mark National Radon Action Month.

“It’s estimated that nearly one in every 15 U.S. homes has elevated radon levels and there’s no way of knowing if yours is one of them without testing,” said Jens Housley, AprilAire’s senior category manager for radon. “We are on a mission to help people stay safe in their homes so, to help raise awareness about radon, we’re giving away thousands of tests in our headquarters region of Milwaukee and Madison as well as in the area of Allentown, Penn., all areas widely known for elevated levels.”

Radon is an odorless, colorless radioactive gas that comes from the natural decay of uranium found in nearly all soils and it’s the number one cause of lung cancer in nonsmokers leading to an estimated 21,000 deaths each year. Measured by pCi/L (picocuries per liter of air), the Environmental Protection Agency (EPA) recommends mitigation strategies when radon levels are greater than or equal to 4.0 pCi/L – the equivalent of having 200 chest x-rays per year or smoking eight cigarettes every day.

More than 30 states are estimated to have elevated radon levels and AprilAire would like to help those residents stay safe and healthy in their homes. The company has targeted three areas for the free test kit giveaways: its hometown of Madison, Wis. (Dane County), near Milwaukee (Waukesha County), and hot spots in Pennsylvania including Allentown (Lehigh County), Reading (Berks County), and King of Prussia (Montgomery County). All these areas are considered Zone 1, meaning homes in the area have the highest potential of elevated radon levels compared to the rest of the country.

Per Wisconsin Department of Health Data, 50.8% of tests in Dane County showed 4.0 pCi/L levels or higher and, in Waukesha County, 61.3% had such elevated levels. In Pennsylvania, Lehigh County reported 46% of tests above 4.0, 50% of tests in Berks County were above 4.0, and Montgomery County reported 28% of tests were above 4.0.

“All homes have some levels, but when they’re elevated it’s unsafe. Without a test you won’t know your health is in danger,” Housley said. “As a whole, our company provides healthy indoor air and radon is now a key product line. We even offered employees free tests because health really does begin at the workplace as well as at home.”

Travis Blackburn is one of those employees who tested for radon and found elevated levels. He and his family discovered through AprilAire’s charcoal test, one of the tests the company is currently giving away for National Radon Action Month, that the levels in their Dane County home had radon levels of 9.7 pCi/L, well over double the amount at which the EPA recommends action.

“Last February we installed an AprilAire mitigation system, and the results are amazing,” Blackburn said. “We went from 9.7 down to 0.3 pCi/L. I am grateful to work for a company with such an impactful mission!”

AprilAire is providing up to 1,000 test kits in Dane County, where its headquarters is located, through its professional HVAC partner Harker Heating & Cooling. Up to another 1,000 will be available through Kettle Moraine Heating & Air Conditioning in nearby Milwaukee. And in Pennsylvania, the tests will be distributed by SWAT Environmental. To get a free test, homeowners should contact the AprilAire partner in their respective regional area.

AprilAire is focused on radon awareness and education all year but especially during January. In addition to the free test kit program this month, the company has participated in the popular video project, Build Show. The Build Show Build Boston episode airing on January 9 will focus on homeowner Scott Rodman discovering elevated radon levels and employing a radon mitigation system from AprilAire.

Other AprilAire initiatives during January will highlight the dangers of radon, the value of testing and mitigation, and the fact that testing is never a one-and-done proposition because levels fluctuate so testing should recur on a regular basis. To disseminate these messages, the company will use direct mail, social media advertising, public relations, and a variety of other marketing tactics including web, online, and professional partner promotions. Additionally, Tamara Day of HGTV and Magnolia Network will host a radon test kit giveaway, have a radon mitigation system installed in her own home, and post a “play-by-play” of these important healthy indoor air messages on her influencer channels.

Additionally, AprilAire will host weekly 30-minute live training courses during January through the AprilAire Academy for its network of professional HVAC partners nationwide. Topics covered throughout the month in these complimentary webinar sessions include testing for radon in your service area, installing radon alarms, replacing faulty radon fans, and turning passive systems into powered systems for improved radon control. Sessions begin today, January 5, and partners can register here or contact AprilAire at 800-334-6011.

AprilAire offers a host of IAQ products for healthy living and its signature solution is the AprilAire Healthy Air System® which delivers healthy air to the entire house via the existing HVAC system with a multi-pronged approach for clean air: proper humidity, fresh air ventilation, and air purification. The system also provides comprehensive IAQ control and radon mitigation. Other products include air purifiers and a complete line of high efficiency air filters which require less energy to pull air through compared to traditional filters. Visit the AprilAire website to learn more about maintaining proper indoor air quality and find the right solution for residences, contact a local AprilAire Healthy Air Professional for a consultation.

About AprilAire

AprilAire is on a mission to make homes healthy. We believe everyone deserves Healthy Air and envision a future with Healthy Air in every home. We value healthy living, customer inspired innovation, simplicity of design, straight talk and delivering real results as promised, and most importantly making a positive difference in the lives of our customers, families, and communities. Headquartered in Madison, Wisconsin since 1954, AprilAire has been creating and delivering Healthy Air solutions to manage air purity, humidity, fresh air supply, radon mitigation, and temperature for all types of homes, in all environments. We have an unparalleled reputation as the brand of choice among tens of thousands of professional contractors and make a Healthy Air difference in the lives of the millions of families who rely on our products every day. To learn how to turn your house into a Healthy Home with the AprilAire Healthy Air System® and learn about other solutions, visit aprilaire.com.

# # #

Sartorius collaborates with RoosterBio to advance downstream purification processes for the manufacture of exosomes


News Image

“Sartorius, a leading solutions provider is delighted to enter into a collaboration with RoosterBio to develop a robust process for Exosome production.” – Michaela Pischke, Head of Business Area Separation Technologies at Sartorius

The life science group Sartorius extended a strategic collaboration partnership agreement with RoosterBio Inc. (RoosterBio) to address purification challenges and establish scalable downstream manufacturing processes for exosome-based therapies. Through this collaboration, Sartorius and RoosterBio will provide best-in-class solutions and expertise for a human mesenchymal stem/stromal cell (hMSC) – based exosome production platform that delivers industry-leading yield, purity, and potency. Additionally, this collaboration will focus on the development of comprehensive analytical techniques for the characterization of exosomes and the entire spectrum of extracellular vesicles (EVs) to establish quantitative strategies for quality control of exosome purification intermediates and final drug product. Collaboration between Sartorius and RoosterBio in the field of Cell and Gene therapy has existed for almost two years for the industrialization of cell-based regenerative cures. It now will take a step further to commercialize the Exosome production and purification process using our technologies.

Sartorius and RoosterBio will develop scalable platform purification processes using Sartorius’ comprehensive toolbox of solutions to maximize exosome productivity while maintaining therapeutic attributes. Sartorius’s Biostat STR® manufacturing bioreactor platform, process analytical technologies (PAT) toolbox, along with RoosterBio’s hMSC banks, RoosterNourish™ hMSC cell growth medium, and RoosterCollect™ EV production medium will be used for upstream manufacture of exosomes at large scale. For the development of downstream purification methods, Sartorius’s scalable filtration equipment, Sartoflow® Smart and Sartoflow® Advanced will be leveraged for clarification, concentration, and formulation of exosomes in combination with column chromatography unit operations. Sartorius’ analytical platforms, including PATfix® HPLC, Virus Counter®, and Incucyte®, will be utilized for automated real-time process analysis and evaluation of purification process efficiency. This collaborative development effort, conducted in RoosterBio’s state-of-the-art process development laboratories in Frederick, MD, will simplify multi-step therapeutic development processes by providing robust, end-to-end platform technologies and protocols that researchers can easily adopt to accelerate development timelines and incorporate a scalable platform approach into their manufacturing processes.

“Sartorius, a leading solutions provider is delighted to enter into a collaboration with RoosterBio to develop a robust process for Exosome production. With advanced and innovative Sartorius downstream technologies for both chromatography and filtration along with state-of-the-art analytical tools, we would work with RoosterBio team for process development for this emerging modality,” said Michaela Pischke, Head of the Business Area Separation Technologies at Sartorius. “Together we merge our technologies, RoosterBio’s Clinical MSC & EV solution portfolio and Sartorius’ regulatory-compliant bioprocess manufacturing solutions, and industry expertise to deliver the bundled solutions for enabling fast-track early drug development and robust, cost-effective, scalable manufacturing process for Exosomes.”

“We are delighted to continue our highly impactful partnership with Sartorius, as this collaboration builds upon our previous process development initiative to establish scalable stirred tank bioreactor expansion processes for hMSCs,” said Tim Kelly, Ph.D., CEO of RoosterBio. “Exosomes offer extremely high utility as a new therapeutic modality with the potential to address unmet medical needs. The cell and gene therapy industry will greatly benefit from access to robust, scalable, end-to-end solutions for the production and characterization of native and engineered exosome therapeutics. By combining our industry-leading MSC and exosome technology platform with Sartorius’ best-in-class bioprocess solutions and expertise, we will deliver transformational value to advance the clinical development of this new class of therapies to patients around the world.”

Sartorius and RoosterBio will leverage the data from this collaboration to provide application notes, technology presentations, and other guidance materials designed to address the most significant challenges faced by the biomanufacturing industry.

A profile of Sartorius

The Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services Division concentrates on serving the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The Bioprocess Solutions Division, with its broad product portfolio focusing on single-use solutions, helps customers to manufacture biotech medications and vaccines safely and efficiently. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions of complementary technologies. In fiscal 2021, the company earned sales revenue of some 3.45 billion euros. At the end of 2021, nearly 14,000 people were employed at the Group’s approximately 60 manufacturing and sales sites, serving customers around the globe.

About RoosterBio Inc.

RoosterBio accelerates human mesenchymal stem/stromal cell (hMSC) and extracellular vesicle (EV) product and process development to fuel the rapid commercialization of scalable advanced therapies. Our high-quality hMSCs, bioprocess media, genetic engineering tools, and EV production solutions are paired with expert bioprocessing knowledge to progress therapeutic developers from concept to first-in-human testing and commercial manufacturing at reduced cost and increased productivity. With optimized, scalable processes, Type 2 Drug Master Files, and cGMP products, we have enabled therapeutic programs to traverse their path to clinical translation in under 1 year. RoosterBio is driven by the client’s success and creating a world where safe and effective regenerative medicines are rapidly developed and widely available on a global scale.

Follow Sartorius on Twitter @Sartorius_Group and on LinkedIn.

Share article on social media or email:

Celebrate Healthy Sleep on March 17, the Next World Sleep Day


News Image

World Sleep Society encourages individuals and organizations with public platforms to promote sleep health on World Sleep Day.

World Sleep Society is issuing a global call to action to organize sleep health awareness activities on and around Friday, March 17, 2023, the next World Sleep Day. Members of World Sleep Society, sleep experts and community health advocates in over 70 countries will be organizing local, regional and national activities to promote sleep health. Join us!

A Call to Action – Celebrate Healthy Sleep!

  • Interview a credible sleep expert for your World Sleep Day content
  • Organize an awareness activity in your community
  • Write, create or otherwise connect with your public audience about sleep health

The 2023 Theme: Sleep Is Essential for Health

The theme for the upcoming World Sleep Day is Sleep is Essential for Health. Just like eating well and exercising, sleep is a behavior that is foundational to one’s physical, mental and social well-being. “Just because sleep is a natural behavior does not mean that sleep should be taken for granted,” says Fang Han, MD, Co-chair of World Sleep Day 2023. Co-chair Lourdes DelRosso, MD, PhD adds that “People should think about sleep like they do other important healthy behaviors such as exercise – as something to reflect upon and, when appropriate, improve so that one can feel better and remain healthier over time.”

Activity organizers can find support and resources on worldsleepday.org, the official website of World Sleep Day. Activity submissions are now open and are being freely published online after review. Plan and submit your activity soon!

Connect with a Sleep Expert

Members of the media, including those in non-English-speaking markets, can contact World Sleep Society to help schedule interviews and discussions about sleep health with sleep experts. World Sleep Society encourages individuals and organizations with public platforms to promote sleep health on World Sleep Day. “Our patients and people of all ages across the world can enhance their overall health and well-being by prioritizing sleep and embracing strategies to improve sleep and circadian health. The more our members, activity organizers and the media can share evidence-supported knowledge about sleep and circadian health, the better,” says Phyllis C. Zee, MD, PhD, president of World Sleep Society.

The upcoming World Sleep Day will be the 17th annual call to action to celebrate sleep health. World Sleep Day is organized by World Sleep Society – an international society of sleep researchers and clinicians – and is chaired by Dr. Lourdes DelRosso of University of California San Francisco – Fresno and Dr. Fang Han of Peking University People’s Hospital. Learn more about World Sleep Day and find additional resources at worldsleepday.org.

About World Sleep Society

World Sleep Society is a non-profit organization registered in the United States with a global membership representing over 80 countries. The mission of World Sleep Society is to advance sleep health worldwide. World Sleep Society fulfills this mission by encouraging and facilitating sleep health education, research and patient care throughout the world, particularly in places underserved by sleep medicine. Learn more about World Sleep Society programs at worldsleepsociety.org.

Share article on social media or email:

Egnyte Announces New Offering Providing Early-Stage Life Science Startups a Year of Egnyte’s Platform at No Cost


Egnyte the secure platform for content collaboration and governance, recently announced it will be providing early-stage life sciences innovators complimentary access to their award-winning Egnyte for Life Sciences platform. This offer is designed to accelerate “time to patient” for life sciences innovators and will give companies a full year of access to Egnyte’s platform to help them scale and optimize their business, collaborate across their partner ecosystems, and manage risk and regulatory compliance.

“More than ever, agility, speed and collaboration must become core competencies for every life sciences startup,” said Ronen Vengosh, vice president of Life Sciences at Egnyte. “Egnyte is proud to make our cloud-based data and document collaboration solutions even more widely available to the companies who are pioneering the next generation of treatments that will positively improve people’s lives.”

The Egnyte for Life Sciences platform enables pre-clinical and clinical-stage biotechs with limited IT resources to collaborate seamlessly on diverse data sets with their partner ecosystems, while maintaining the required levels of data control and compliance with industry regulations.

“Egnyte’s platform provides a reliable and secure collaboration environment that supports our current data management needs. It’s easy to use and can scale with us as our team grows,” said Joe Hunter, M.S., co-founder and co-CEO of VaxSyna. “As we proceed through pre-clinical trials and move to clinical trials, we have peace of mind knowing Egnyte’s cloud-based data and document collaboration platform meets regulatory requirements and will grow with us as we continue to focus on tackling global health challenges with our novel vaccine platform.”

Egnyte’s free offering is available exclusively to early-stage life sciences startups. Companies who qualify for the offer will receive 12 months of access to the platform for up to five users. For more information about the offer, click here.

Egnyte for Life Sciences allows companies to securely share and integrate data across their ecosystem of internal and external collaborators in real time. Unlike consumer-grade cloud content sharing applications, the platform provides built-in controls to maintain the quality and integrity of data over its lifecycle. The platform integrates with business and life science applications including Microsoft Office, Google, AWS, and ELNs and provides a solution for secure data collection from sites and partners. Egnyte’s Life Science platform is a fully validated, audit-ready environment compliant with 21 CFR Part 11 for regulated and unregulated data.

About Egnyte

Egnyte is the secure multi-cloud platform for content security and governance that enables organizations to better protect and collaborate on their most valuable content. Established in 2007, Egnyte has democratized cloud content security for more than 17,000 organizations, helping customers improve data security, maintain compliance, prevent and detect ransomware threats, and boost employee productivity on any app, any cloud, anywhere. For more information, visit http://www.egnyte.com.

Share article on social media or email:

NEDHSA seeks to inspire region through “Sour Grapes” stageplay


NEDHSA seeks to inspire region through “Sour Grapes” stageplay

NEDHSA seeks to inspire region through “Sour Grapes” stageplay

“We believe there is medicine in creative expression, and the arts can help a person come alive in ways traditional treatment options can’t,” Dr. Sizer said.

Northeast Delta Human Services Authority (NEDHSA) and Christal Wheeler Productions are partnering to produce two showings of “Sour Grapes,” a show made up of three short stories all based on the same theme, “Generational Curses: How we deal with them and God’s grace for us.” The theatrical production is set for Saturday, January 28, with the performances starting at 2:30 p.m. and 6 p.m., at the Jack Howard Theatre in Monroe. Both shows are free.

The production is part of NEDHSA’s Faith-Based initiative, which provides in-depth training in four key areas: Awareness, Readiness, Development and Sustainability. NEDHSA’s Faith-Based initiative works collectively and one-on-one with faith leaders and congregations to help develop and expand ministerial capacity so that addictive and mental health disorders can be comprehensively addressed regionally.

NEDHSA Executive Director Dr. Monteic A Sizer said the agency, “intends to help make Northeast Louisiana a regional creative hub, a preferred destination that will generate much-needed regional economic development, diversity, job creation, and more.”

“We must do different things to educate, engage and inspire the public,” Dr. Sizer said. “We’re helping people in our region to understand addiction and mental health issues with this innovative prevention approach. We want them to understand that all people have value and potential. This production is designed to challenge us, sadden us, and motivate us towards collective action.”

“We believe there is medicine in creative expression, and the arts can help a person come alive in ways traditional treatment options can’t,” Dr. Sizer said. “We intend to help create an environment where dreams are realized, families are strong, bodies are healthy, community institutions are thriving, and spirits are renewed.”

NEDHSA chose Christal Wheeler’s “Sour Grapes” script because of the impact of generational curses can have on mental health and addiction disorders. Additionally, Wheeler is engaging at-risk youth and young adults in the production, allowing them to learn and develop vocational and life skills by producing a feature-length play.

She said her production studio likes to make its audiences think, “why fit in when you were born to stand out?”

“This show is an original, heartfelt, raw body of work inspired by Jeremiah 31:30,” Wheeler said. “It takes a creative spin on traditional theatre and unapologetically introduces the topic of generational curses and how we deal with them.”

Wheeler said that attendees will be “uplifted and encouraged through the three Acts as we explore the highs and lows of life.”

“Each Act shares a different story with different characters and perspectives,” Wheeler said. “Having multiple storylines increases the chances of audience members identifying with the theme and ultimately seeing themselves in some way.”

Wheeler added, “We promise a unique and uplifting experience for all who attend.”

To reserve free tickets, visit nedhsadrama2023.eventbrite.com.

Share article on social media or email:

SightMD and Sight Growth Partners will be hosting an open house on…


SightMD and Sight Growth Partners will be hosting an open house on Saturday, February 3rd, 2023 from 11:00am – 3:00pm at the Sight Growth Partners Headquarters located at 125 Kennedy Drive, Hauppauge…

(PRWeb January 05, 2023)

Read the full story at https://www.prweb.com/releases/sightmd_and_sight_growth_partners_will_be_hosting_an_open_house_on_saturday_february_3rd_2023/prweb19081060.htm

Importance of Early Integrated Evidence Strategy for Cell & Gene Therapies, Upcoming Webinar Hosted by Xtalks


An integrated, cross-functional evidence strategy can ensure that the right processes, tools, culture, governance and training are available to support evidence generation and evidence dissemination activities.

The healthcare ecosystem is a complex network of stakeholders that requires a focused engagement strategy to navigate the evolving landscape. Traditional clinical development is primarily focused on meeting evidentiary needs for regulatory authorities and does not necessarily meet the needs of the broader network of diverse stakeholders, each with their own engagement preferences and evidence needs. An integrated, cross-functional evidence strategy can ensure that the right processes, tools, culture, governance and training are available to support evidence generation and evidence dissemination activities. Many organizations already work in a cross-functional manner to address their evidentiary needs; however, the critical next step is truly integrated thinking around value creation as well as a refined strategy to generate and disseminate the right evidence to the right stakeholders at the right time.

Integrated Evidence Strategy represents the next generation of clinical development and could be particularly important for companies developing cell and gene therapies (CGT), for whom the complexities of CGT have introduced new uncertainties among stakeholders across the healthcare ecosystem. For example, as a result of the high upfront costs of CGT, payers are beginning to introduce Outcomes-Based Contracts, which stipulate that the amount a health plan pays for a therapy depends on how effective the therapy is at treating the condition. An Integrated Evidence Strategy can address these evolving payer dynamics to ensure a successful product launch and lifecycle while also protecting companies from risk by proactively anticipating and meeting critical evidentiary needs in a timely manner.

Register for this webinar and find out through case studies and panel discussion, the value of defining an Integrated Evidence Strategy early on in cell and gene therapy development.

Join experts from Syneos Health, Colin Oliver, Managing Director, Consulting; and Jessica B. Lee, Senior Managing Director, Commercial Advisory Group, Head of Oncology, Cell and Gene Therapy Consulting, for the live webinar on Wednesday, January 18, 2023, at 1pm EST (10am PST).

For more information, or to register for this event, visit Importance of Early Integrated Evidence Strategy for Cell & Gene Therapies.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email: